Revvity Inc (RVTY)
126.06
-0.28
(-0.22%)
USD |
NYSE |
Sep 27, 16:00
126.02
-0.04
(-0.03%)
After-Hours: 20:00
Revvity SG&A Expense (Annual): 1.023B for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 1.023B |
December 31, 2022 | 1.026B |
December 31, 2021 | 975.19M |
December 31, 2020 | 716.46M |
December 31, 2019 | 815.32M |
December 31, 2018 | 811.91M |
December 31, 2017 | 626.02M |
December 31, 2016 | 590.47M |
December 31, 2015 | 587.22M |
December 31, 2014 | 648.21M |
December 31, 2013 | 581.90M |
December 31, 2012 | 627.37M |
December 31, 2011 | 624.39M |
December 31, 2010 | 487.31M |
December 31, 2009 | 468.29M |
December 31, 2008 | 524.82M |
December 31, 2007 | 444.41M |
December 31, 2006 | 376.85M |
December 31, 2005 | 365.46M |
December 31, 2004 | 362.32M |
Date | Value |
---|---|
December 31, 2003 | 386.40M |
December 31, 2002 | 431.30M |
December 31, 2001 | 411.14M |
December 31, 2000 | 418.98M |
December 31, 1999 | 327.10M |
December 31, 1998 | 203.70M |
December 31, 1997 | 221.00M |
December 31, 1996 | 290.90M |
December 31, 1995 | 284.90M |
December 31, 1994 | 278.20M |
December 31, 1993 | 234.60M |
December 31, 1992 | 242.00M |
December 31, 1991 | 223.10M |
December 31, 1990 | 195.90M |
December 31, 1989 | 179.90M |
December 31, 1988 | 169.30M |
December 31, 1987 | 151.40M |
December 31, 1986 | 133.20M |
December 31, 1985 | 130.10M |
December 31, 1984 | 120.80M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
716.46M
Minimum
2020
1.026B
Maximum
2022
911.01M
Average
975.19M
Median
2021
SG&A Expense (Annual) Benchmarks
Avantor Inc | 1.507B |
Agilent Technologies Inc | 1.634B |
Bionano Genomics Inc | 93.50M |
Bruker Corp | 730.10M |
Azenta Inc | 316.28M |